Celligenics is a Singapore Biotechnology Company, spun-off from the Agency of Science, Technology, and Research (A*STAR) Singapore’s lead public research and development agency. We are pushing the frontier in the discovery and development of novel therapeutic and wellness solutions, harnessing the power of regenerative biologics, to support the body in repairing, regenerating, and restoring itself to a state of well-being.

Through a decade of research and development, our company has developed a proprietary platform technology that is able to isolate a unique subpopulation of stem cells discovered within the umbilical cord that demonstrates high levels of stem-ness and stability, with strong growth potential, and extract a proprietary and patent-pending active ingredient that has the ability to confer superior regenerative capabilities in comparison to existing offerings.

This active ingredient is known scientifically as stem cell secretomes, which is made up of a diverse array of proteins released by stem cells into the extracellular space, notably consisting of growth factors, cytokines, other signalling proteins, as well as exosomes, and other bio-membrane vesicles, and constitutes the building block of the body’s repair and regeneration processes.

Our business is in the development of applications that harnesses the regenerative potential of our active ingredient, and stay true to our vision and mission, as stated above.